Akarna Therapeutics, Ltd.
Records under this name other than patents Akarna Therapeutics, Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Akarna Therapeutics, Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,466,143 | Azepine Derivaties as Pharmaceutical Agents Formerly held In force · High confidence | In force | High confidence | |
| US 10,233,187 | Fused Bicyclic Compounds for the Treatment of Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,167,294 | Fused Bicyclic Compounds for the Treatment of Disease Formerly held In force · High confidence | In force | High confidence | |
| US 10,793,577 | Fused Bicyclic Compounds for the Treatment of Disease Formerly held In force · High confidence | In force | High confidence | |
| US 10,421,759 | Fused Bicyclic Compounds for the Treatment of Disease Formerly held In force · High confidence | In force | High confidence | |
| US 8,524,704 | Azepinoindole Derivatives As Pharmaceutical Agents Term ended Term ended Apr 25, 2024 · High confidence | Term ended | Term ended Apr 25, 2024 | High confidence |
| US 7,485,634 | Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents Term ended Term ended Apr 20, 2024 · High confidence | Term ended | Term ended Apr 20, 2024 | High confidence |
| US 7,595,311 | Azepinoindole Derivatives as Pharmaceutical Agents Term ended Term ended Apr 20, 2024 · High confidence | Term ended | Term ended Apr 20, 2024 | High confidence |
| US 8,748,440 | Quinazolinone Modulators of Nuclear Receptors Term ended Term ended Jan 12, 2024 · High confidence | Term ended | Term ended Jan 12, 2024 | High confidence |
| US 8,133,992 | Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents Term ended Term ended Aug 25, 2023 · High confidence | Term ended | Term ended Aug 25, 2023 | High confidence |